SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (391)3/15/1999 10:10:00 PM
From: LLCF  Read Replies (1) | Respond to of 712
 
Thanks for the info on CORR... I get MTSL as well, but FYI doubt that they would appreciate your posting his opinion for all to see without paying for it... tough call there. Anyway, CORR is an obvious candidate for CHIR, they have said publicly that there are 3 areas they want to pursue aquisitions in. Also, CORR has $3 a share in cash and trades for $8 while moving to "burn neutral" position (hopefully) soon. This stock is silly cheap IMO and I bought more today, and will purchase tomorrow. For those who follow such things, the RSI charts signal $1 upside in the stock soon.

DAK



To: Edscharp who wrote (391)3/21/1999 9:46:00 AM
From: Joe Dancy  Read Replies (2) | Respond to of 712
 
Jim McCamant as you note likes CORR and the biotech sector in general - we interviewed him for the IFC site on Silicon Investor and you can listen to his outlook for biotechs at audioinvestor.com and read a summary of his take at techstocks.com

Be warned, I do the audio interview and I'm no Louis Rukeyser - but McCamant was interesting and informative, and mentioned CORR and why he liked.

Joe


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News